A Focused Portfolio for
Global Impact
Five Generations of Integrity and Impact
Our expansive portfolio includes both Essential Medicines and a full range of product offerings designed to address chronic and acute care needs, all supplied across a variety of dosage forms.
We manage a robust and reliable supply chain anchored by our substantial manufacturing capacity. This capacity allows us to consistently offer a diverse range of products for multiple indications, ensuring continuity of supply for our partners.
Essential Medicines for Global Health
A significant portion of our portfolio includes products featured on the World Health Organization (WHO) Essential Medicines List (EML). By manufacturing these life-saving generics, we actively contribute to global public health initiatives and collaborate closely with large global institutions and non-governmental organizations to ensure widespread access.
In Addition, we are proud to have several products WHO Prequalified to combat Malaria and Tuberculosis.
Backward Integration: The Strategic Advantage
Our position as a preferred supplier is strengthened by our backward integration capabilities, featuring in-house API manufacturing within the SK Group.
Regulatory accreditations and APIs across multiple therapeutic categories, positions S Kant to be a supplier of choice for partners seeking quality, reliability, and value
Please download the complete listing of Active Pharmaceutical Ingredients (APIs) offered by the SK Group.
Let’s Start a Conversation
Reach out to our team for collaborations, partnerships, or inquiries.